Related Experiment Video
Updated: May 30, 2025

13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
12.4K
Spatial Epidemiology of Human Papillomavirus Screening Coverage in Mexico, 2013-2019
Oscar Alejandro Palacios Rodríguez1, Miguel Galarde López2, Carlos Quezada Sánchez3
1Faculty of Psychology, Autonomous University of San Luis Potosí, San Luis Potosi, Mexico.
Asian Pacific Journal of Cancer Prevention : APJCP
|January 28, 2025
Summary
Human Papillomavirus (HPV) screening coverage in Mexico declined significantly from 2013 to 2019. This decrease, alongside identified geographic disparities in HPV infections, necessitates a reevaluation of current strategies for cervical cancer elimination.
Area of Science:
- Public Health
- Epidemiology
- Oncology
Background:
- Cervical cancer remains a significant global health concern, with Human Papillomavirus (HPV) infection being the primary causative agent.
- Effective screening programs are crucial for early detection and prevention of cervical cancer.
- Understanding the spatial distribution and trends of HPV infections is vital for targeted public health interventions.
Purpose of the Study:
- To evaluate the coverage of the national HPV screening program across Mexico's 32 federal states from 2013 to 2019.
- To analyze the spatial patterns and trends of HPV infections within Mexico during the same period.
- To identify geographic disparities in HPV screening coverage and infection rates.
Main Methods:
- An exploratory, ecological study design was employed using national health program data from 2013-2019.
- Adjusted rates per 100,000 females (aged 25-64) were calculated and georeferenced to assess screening coverage and HPV positivity.
- Spatial cluster analysis was utilized to identify significant geographic patterns and trends in HPV detection.
Main Results:
- Over 2.5 million HPV screening tests were analyzed, revealing an overall HPV positivity prevalence of 11.1%.
- A substantial decrease in HPV screening test coverage was observed, dropping from 2,835.4 to 0.8 per 100,000 females between 2013 and 2019.
- A spatial cluster of states with a higher probability of HPV detection was identified, indicating geographic variations in infection prevalence.
Conclusions:
- The study identified a significant decline in HPV screening program coverage and notable geographic differences in HPV infections across Mexico.
- These findings suggest that current strategies for HPV prevention and detection may be insufficient to accelerate cervical cancer elimination.
- A critical reconsideration of public health strategies is recommended to address the identified coverage gaps and spatial inequalities.
Keywords:
Human papillomavirus (HPV)Papillomavirus Infectionsnational health programspublic healthspatial epidemiology
